Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 23 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
NCT07160725
- Conditions
- Solid Tumours
- Locations
-
- Local Institution - 0033 Irvine, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California, Irvine (UCI) Health - UC Irvine Medical Center Orange, California, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT07224425
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- University of Louisville Louisville, Kentucky, United States
- Tennessee Oncology, PLLC - Elliston Place Plaza DDU Nashville, Tennessee, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- University of Virginia Health System Charlottesville, Virginia, United States
NCT06581432
- Conditions
- Solid Tumours
- Locations
-
- Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
- University of Arizona Comprehensive Cancer Center Tucson, Arizona, United States
- Precision NextGen Oncology Beverly Hills, California, United States
- Scripps Cancer Center Torrey Pines La Jolla, California, United States
NCT07446855
- Conditions
- Solid Tumours
- Locations
-
- Research Site New York, United States
- Research Site Providence, Rhode Island, United States
- Research Site Houston, Texas, United States
- Research Site Fairfax, Virginia, United States
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
- Locations
-
- Precision NextGen Oncology and Research Center Beverly Hills, California, United States
- Sarcoma Oncology Center Santa Monica, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Chris O'Brien Lifehouse Sydney, New South Wales, Australia
Recruiting
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
NCT06725758
- Conditions
- Solid Tumours
- Locations
-
- Valkyrie Clinical Trials Los Angeles, California, United States
- UC Irvine Health Orange, California, United States
- Siteman Cancer Center St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT01956669
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
- Locations
-
- Novartis Investigative Site Long Beach, California, United States
- Novartis Investigative Site Madera, California, United States
- Novartis Investigative Site Orange, California, United States
- Novartis Investigative Site Palo Alto, California, United States
NCT04179071
- Conditions
- Solid Tumours
- Locations
-
- Research Site Baltimore, Maryland, United States
NCT03333824
- Conditions
- Solid Tumours
- Locations
-
- Research Site Bingham Farms, Michigan, United States
- Research Site Detroit, Michigan, United States
- Research Site Lebanon, New Hampshire, United States
- Research Site Cincinnati, Ohio, United States
NCT02161770
- Conditions
- Neoplasms, Solid Tumours
- Locations
-
- Research Site San Diego, California, United States
- Research Site Atlanta, Georgia, United States
- Research Site Detroit, Michigan, United States
- Research Site Cleveland, Ohio, United States
NCT01767454
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site St Louis, Missouri, United States
NCT00732420
- Conditions
- Solid Tumours
- Locations
-
- GSK Investigational Site Philadelphia, Pennsylvania, United States
- GSK Investigational Site Amsterdam, Netherlands
- GSK Investigational Site Utrecht, Netherlands
NCT00483860
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +6 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Lebanon, New Hampshire, United States
- GSK Investigational Site Amsterdam, Netherlands
- GSK Investigational Site Utrecht, Netherlands
NCT00687622
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Fort Myers, Florida, United States
- GSK Investigational Site Ocoee, Florida, United States
NCT00136578
- Conditions
- Solid Tumours
- Locations
-
- GSK Investigational Site Nashville, Tennessee, United States
- GSK Investigational Site Newcastle upon Tyne, Northumberland, United Kingdom
NCT00742261
- Conditions
- Solid Tumours
- Locations
-
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Houston, Texas, United States
Completed
Dose-Escalation Study of GSK2126458
NCT00972686
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site New Brunswick, New Jersey, United States
- GSK Investigational Site Chapel Hill, North Carolina, United States
- GSK Investigational Site Dallas, Texas, United States
NCT02056392
- Conditions
- Solid Tumours
- Locations
-
- Research Site Overland Park, Kansas, United States
NCT02093728
- Conditions
- Solid Tumours
- Locations
-
- Research Site Overland Park, Kansas, United States
NCT02063204
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
- Locations
-
- Research Site Orlando, Florida, United States